L-Arginine-L-pyroglutamate
CAS : 56265-06-6
Ref. 3D-FA39360
| 1g | Arrêté | ||
| 2g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 25g | Arrêté |
Informations sur le produit
Nom :
L-Arginine-L-pyroglutamate
Synonymes :
- <span class="text-smallcaps">L</smallcap>-Arginine, compd. with 5-oxo-<smallcap>L</span>-proline (1:1)
- <span class="text-smallcaps">L</smallcap>-Proline, 5-oxo-, compd. with <smallcap>L</span>-arginine (1:1)
- Arg-Pyr
- Arginine PCA
- Arginine pyroglutamate
- L-Arg L-Pyr
- L-Arginine L-Pyroglutamic acid
- L-Arginine Pyroglutamate
- N~5~-(diaminomethylidene)-L-ornithine-5-oxo-L-proline (1:1)
Description :
L-Arginine-L-pyroglutamate is a basic protein that is synthesized from L-arginine and pyroglutamic acid. It has chemotactic activity, meaning that it can cause cells to migrate towards the compound. L-Arginine-L-pyroglutamate has been shown to have protease activity against a number of tissue proteins, including collagenases and elastases. The expression plasmid containing the gene for this protein was used to diagnose squamous cell carcinoma in women as well as cervical cancer in mice. The use of L-Arginine-L-pyroglutamate in prognosis and diagnosis of hyperproliferative diseases such as skin cancer may be a promising area for future research.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
